|
Volumn 7, Issue 17 SUPPL., 2001, Pages
|
Treatment of deep vein thrombosis using low-molecular-weight heparins
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTICOAGULANT AGENT;
ARDEPARIN;
DALTEPARIN;
ENOXAPARIN;
HEPARIN;
INFUSION FLUID;
LOW MOLECULAR WEIGHT HEPARIN;
NADROPARIN;
REVIPARIN;
TINZAPARIN;
WARFARIN;
BLEEDING;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST CONTROL;
DEEP VEIN THROMBOSIS;
DOSE RESPONSE;
DRUG BIOAVAILABILITY;
DRUG COST;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG INFUSION;
DRUG SAFETY;
DRUG USE;
FOLLOW UP;
HEALTH CARE COST;
HEALTH INSURANCE;
HOME CARE;
HOSPITALIZATION;
HUMAN;
INCIDENCE;
KIDNEY FAILURE;
MEDICAL CARE;
META ANALYSIS;
MORBIDITY;
MORTALITY;
MULTICENTER STUDY;
OBESITY;
OUTPATIENT CARE;
PATIENT CARE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
PROPHYLAXIS;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
RISK ASSESSMENT;
THROMBOCYTOPENIA;
TREATMENT OUTCOME;
AMBULATORY CARE;
ANTICOAGULANTS;
BIOLOGICAL AVAILABILITY;
HALF-LIFE;
HEPARIN;
HEPARIN, LOW-MOLECULAR-WEIGHT;
HUMANS;
INTERNATIONAL NORMALIZED RATIO;
PRACTICE GUIDELINES;
UNITED STATES;
VENOUS THROMBOSIS;
|
EID: 0035198865
PISSN: 10880224
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (8)
|
References (20)
|